Journal
PURINERGIC SIGNALLING
Volume 5, Issue 2, Pages 223-232Publisher
SPRINGER
DOI: 10.1007/s11302-009-9138-2
Keywords
ATP; Purinergic signaling; P2X receptors; Neuronal injury; P2X7 antagonists
Categories
Funding
- NINDS [NS38073, NS39559, NS050315]
- Adelson Program in Neural Repair and Regeneration
- New York State Spinal Cord Research Board
- Robert Packard Center for ALS Research
Ask authors/readers for more resources
ATP-mediated signaling has widespread actions in the nervous system from neurotransmission to regulation of proliferation. In addition, ATP is released during injury and associated to immune and inflammatory responses. Still, the potential of therapeutic intervention of purinergic signaling during pathological states is only now beginning to be explored because of the large number of purinergic receptors subtypes involved, the complex and often overlapping pharmacology and because ATP has effects on every major cell type present in the CNS. In this review, we will focus on a subclass of purinergic-ligand-gated ion channels, the P2X7 receptor, its pattern of expression and its function in the spinal cord where it is abundantly expressed. We will discuss the mechanisms for P2X7R actions and the potential that manipulating the P2X7R signaling pathway may have for therapeutic intervention in pathological events, specifically in the spinal cord.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available